Robert Baughman
Overview
Explore the profile of Robert Baughman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Price L, Kouranos V, Baughman R, Bloom C, Stewart I, Shlobin O, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Apr;
41(1):e2024024.
PMID: 38567554
No abstract available.
2.
Harper L, Tauquir A, Huang S, Wang X, Schupp J, Baughman R, et al.
Respir Med
. 2024 Mar;
226:107605.
PMID: 38537782
Background: Due to the heterogeneity of sarcoidosis, there is a need to define clinical phenotypes to allow for tailoring of clinical care and identification of more homogenous populations to facilitate...
3.
Klein R, Judson M, Barkes B, Maier L, Zeigler J, Culver D, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2023 Mar;
40(1):e2023010.
PMID: 36975058
Introduction: activity tracker device usage can help analyze the impact of disease state and therapy on patients in clinical practice. factors such as age, race, and gender may contribute to...
4.
Derakhchan K, Lou Z, Wang H, Baughman R
Drugs Context
. 2023 Mar;
12.
PMID: 36876155
Background: Prucalopride is a selective serotonin type 4 (5-HT) receptor agonist indicated for treatment of chronic idiopathic constipation (CIC) in adults (2 mg orally, daily). 5-HT receptors are present in...
5.
Sibilia R, Baughman R, Washko D, Lower E, Costea A
J Innov Card Rhythm Manag
. 2022 Dec;
13(11):5244-5254.
PMID: 36570477
Anti-arrhythmics can be useful for ventricular arrhythmias in cardiac sarcoidosis (CS) that are refractory to immunosuppression. However, there is conflicting evidence on the efficacy of immunosuppression for treating arrhythmias in...
6.
Culver D, Aryal S, Barney J, Hsia C, James W, Maier L, et al.
Chest
. 2022 Nov;
163(4):881-890.
PMID: 36356657
Background: Pulmonary sarcoidosis is characterized by the accumulation of immune cells that form granulomas affecting the lungs. Efzofitimod (ATYR1923), a novel immunomodulator, selectively binds neuropilin 2, which is upregulated on...
7.
Sweis J, Sweis N, Ascoli C, Levin B, Avitall B, Rubinstein I, et al.
Respir Med Case Rep
. 2022 Nov;
40:101766.
PMID: 36340865
Background: Tumor necrosis factor (TNF) inhibitors have been used in the treatment of cardiac sarcoidosis, infliximab being the most commonly used. We have previously reported a case of effective treatment...
8.
Sweiss N, Baughman R
Nat Rev Rheumatol
. 2022 Aug;
18(10):557-558.
PMID: 35999390
No abstract available.
9.
Grant M, Heise T, Baughman R
Clin Pharmacokinet
. 2021 Nov;
61(3):413-422.
PMID: 34773608
Background: This study was performed to satisfy a US Food and Drug Administration post-marketing requirement to compare the dose responses for Technosphere Insulin (TI; MannKind Corporation, Westlake Village, CA, USA)...
10.
Manansala M, Baughman R, Novak R, Judson M, Sweiss N
Curr Opin Pulm Med
. 2021 Mar;
27(3):176-183.
PMID: 33779588
Purpose Of Review: Patients on chronic immunosuppressive treatments at baseline are at increased risk of opportunistic infections. These patients are at especially increased risk of morbidity and mortality during the...